Key Documents

View All Documentation

4-Aminobenzoic acid

Name: 4-Aminobenzoic acid
Brand: SIAL
Price: 154 USD
Availability: InStock

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

PABA, Vitamin B_x, Vitamin H₁

Select a Size

Change View

Pack Size	SKU	Availability	Price
60 mg		Available to ship TODAYfromMILWAUKEE	$154.00

About This Item

Linear Formula:

H₂NC₆H₄CO₂H

CAS Number:

150-13-0

Molecular Weight:

137.14

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329830871

MDL number:

MFCD00007894

Beilstein/REAXYS Number:

471605

eCl@ss:

32160406

$154.00

Available to ship TODAYDetails

Request a Bulk Order

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

agency

EP Reference Standard

API family

aminobenzoic acid

manufacturer/tradename

EDQM

mp

187-189 °C (lit.)

density

1.374 g/mL at 25 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Nc1ccc(cc1)C(O)=O

InChI

1S/C7H7NO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,8H2,(H,9,10)

InChI key

ALYNCZNDIQEVRV-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

4-Aminobenzoic acid EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item	PHR1840	100536	A9878
Y0000173 4-Aminobenzoic acid	Supelco PHR1840 Aminobenzoic Acid	Sigma-Aldrich 100536 4-Aminobenzoic acid	Sigma-Aldrich A9878 4-Aminobenzoic acid
manufacturer/tradename EDQM	manufacturer/tradename -	manufacturer/tradename -	manufacturer/tradename -
grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade -	grade -
format neat	format neat	format -	format -
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical	application(s) peptide synthesis	application(s) peptide synthesis
density 1.374 g/mL at 25 °C (lit.)	density 1.374 g/mL at 25 °C (lit.)	density 1.374 g/mL at 25 °C (lit.)	density 1.374 g/mL at 25 °C (lit.)
API family aminobenzoic acid	API family aminobenzoic acid	API family -	API family -

Still not finding the right product?

Explore all of our products under 4-Aminobenzoic acid

hcodes

H412

pcodes

P273 - P501

Hazard Classifications

Aquatic Chronic 3

Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

339.8 °F - closed cup

flash_point_c

171 °C - closed cup

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Production of P-aminobenzoic acid by metabolically engineered escherichia coli.

Daisuke Koma et al.

Bioscience, biotechnology, and biochemistry, 78(2), 350-357 (2014-07-19)

The production of chemical compounds from renewable resources is an important issue in building a sustainable society. In this study, Escherichia coli was metabolically engineered by introducing T7lac promoter-controlled aroF(fbr), pabA, pabB, and pabC genes into the chromosome to overproduce

Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.

Heidi C Schilter et al.

Respiratory research, 16, 42-42 (2015-04-19)

The persistent influx of neutrophils into the lung and subsequent tissue damage are characteristics of COPD, cystic fibrosis and acute lung inflammation. VAP-1/SSAO is an endothelial bound adhesion molecule with amine oxidase activity that is reported to be involved in

Minimally invasive treatment of Peyronie's disease: evidence-based progress.

Gerald H Jordan et al.

BJU international, 114(1), 16-24 (2014-01-23)

Peyronie's disease (PD) is often physically and psychologically devastating for patients, and the goal of treatment is to improve symptoms and sexual function without adding treatment-related morbidity. The potential for treatment-related morbidity after more invasive interventions, e.g. surgery, creates a

View All Related Papers

Global Trade Item Number

SKU	GTIN
Y0000173	04061833802410

Questions

Reviews

No rating value